Healio

Coronary sinus reducer improves symptoms, quality of life for patients with severe CAD

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...
MedPage Today

Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina

ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...
TCTMD

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...
Medscape

Coronary Sinus Reducer an Option for Intractable Angina?

ATLANTA, GA — Despite failing to increase perfusion as hypothesized, a coronary sinus reducer (CSR) in a sham-controlled randomized trial meaningfully reduced angina and improved quality of life in ...
EurekAlert!

Coronary sinus reducer relieves angina, but how it works remains unclear

People with chronic chest pain who received a coronary sinus reducer (CSR)—a stent thought to increase the amount of oxygen-rich blood flowing to the heart muscle—experienced significant reductions in ...
Nasdaq

Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in International Journal of Cardiology

VANCOUVER and MINNEAPOLIS, June 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire-- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, ...
Seeking Alpha

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study

SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Business Insider

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
TCTMD

Coronary Sinus Reducer Mechanism of Action in CMD

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Nasdaq

The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System

VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the United Kingdom’s Interventional ...
BioWorld

Neovasc Reducer achieves primary endpoint in COSIRA

Neovasc (Vancouver, British Columbia) reported top-line results for its COSIRA (Coronary Sinus Reducer for treatment of Refractory Angina) trial assessing the efficacy and safety of the Neovasc ...